- Investing Ideas
- /
- Chinese Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows
Chinese Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows
Results
9
0 new
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
9 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
300705 | CN¥16.69 | -1.4% | -28.1% | CN¥8.3b | CN¥29.00 | PE16.3x | E24.9% | 1.4% | ||
603707 | CN¥13.59 | -6.0% | -1.5% | CN¥22.0b | CN¥17.83 | PS5.7x | E69.6% | 0.7% | ||
300702 | CN¥17.92 | -1.3% | 4.3% | CN¥6.2b | CN¥22.42 | PE141.1x | E71.4% | 0.3% | ||
688073 | CN¥60.83 | 16.0% | 44.8% | CN¥5.4b | CN¥50.00 | PE67.1x | E28.1% | 1.5% | ||
688266 | CN¥74.30 | 9.5% | 64.0% | CN¥19.7b | CN¥79.00 | PS40.3x | E127.9% | n/a | ||
300558 | CN¥51.93 | 1.4% | 22.3% | CN¥21.7b | CN¥58.99 | PE47.3x | E33.4% | 0.3% | ||
002653 | CN¥32.78 | 8.7% | 39.8% | CN¥36.4b | CN¥42.38 | PE76.4x | E35.7% | 0.8% | ||
600422 | CN¥17.17 | -5.1% | -15.2% | CN¥13.0b | CN¥21.90 | PE29.1x | E27.4% | 1.2% | ||
688046 | CN¥16.71 | 5.8% | 23.3% | CN¥6.8b | CN¥14.00 | PE49x | E24.2% | 0.4% |
Page 1 of 1